CD8A and neoplasm: Single-cell sequencing and flow cytometry experiments have revealed that VG161 promotes the infiltration of CD8+ T cells and natural killer (NK) cells into the tumor, thereby altering the tumor’s immune microenvironment and providing a conducive setting for the subsequent use of PD-1 monoclonal antibody.